kainos loboratories,inc Logo

kainos loboratories,inc

Develops and manufactures in-vitro diagnostics and clinical testing reagents.

4556 | T

Overview

Corporate Details

ISIN(s):
JP3205650009
LEI:
Country:
Japan
Address:
文京区本郷二丁目38番18号

Description

Kainos Laboratories, Inc. is a company focused on the development, manufacture, marketing, and distribution of in-vitro diagnostics and pharmaceuticals. As a pioneer in its field, the company specializes in creating innovative clinical testing reagents for biochemical, immunological, and genetic analysis. These diagnostic tools are used to examine biological samples, such as blood and urine, to provide data on a patient's health status. The company is committed to developing and supplying novel products to meet the needs of the medical and healthcare communities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2019-02-04 02:01
四半期報告書-第44期第3四半期(2018/10/01-2018/12/31)
Japanese 129.6 KB
2018-11-02 02:44
四半期報告書-第44期第2四半期(2018/07/01-2018/09/30)
Japanese 155.2 KB
2018-08-02 04:38
四半期報告書-第44期第1四半期(2018/04/01-2018/06/30)
Japanese 127.4 KB
2018-06-22 07:09
有価証券報告書-第43期(平成29年4月1日-平成30年3月31日)
Japanese 640.1 KB
2018-02-02 03:12
四半期報告書-第43期第3四半期(2017/10/01-2017/12/31)
Japanese 127.6 KB
2017-11-02 02:53
四半期報告書-第43期第2四半期(2017/07/01-2017/09/30)
Japanese 151.2 KB
2017-08-03 04:21
四半期報告書-第43期第1四半期(2017/04/01-2017/06/30)
Japanese 121.9 KB
2017-06-20 09:22
訂正有価証券報告書-第42期(2016/04/01-2017/03/31)
Japanese 375.6 KB
2017-06-16 06:02
有価証券報告書-第42期(2016/04/01-2017/03/31)
Japanese 628.0 KB
2017-02-02 02:42
四半期報告書-第42期第3四半期(2016/10/01-2016/12/31)
Japanese 121.6 KB
2016-11-02 03:28
四半期報告書-第42期第2四半期(2016/07/01-2016/09/30)
Japanese 146.0 KB
2016-08-03 04:30
四半期報告書-第42期第1四半期(2016/04/01-2016/06/30)
Japanese 124.6 KB
2016-06-17 08:04
有価証券報告書-第41期(2015/04/01-2016/03/31)
Japanese 633.5 KB
2016-02-02 02:48
四半期報告書-第41期第3四半期(2015/10/01-2015/12/31)
Japanese 124.3 KB
2015-11-02 02:29
四半期報告書-第41期第2四半期(2015/07/01-2015/09/30)
Japanese 142.1 KB

Automate Your Workflow. Get a real-time feed of all kainos loboratories,inc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for kainos loboratories,inc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for kainos loboratories,inc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.